The physiological and immunological profile of children makes pediatric viral infections particularly difficult. Although pediatric populations are a high risk for hospitalization, pediatric-specific antiviral therapy is largely unexplored, resulting in long delays between pediatric drug approvals and commercialization. This chapter discusses inadequacies in the antiviral drug development and administration for pediatric patients and highlights the importance of age specific approaches including regulatory hindrances to approving children's drugs, and the inhumane nature of performing trials in children. The role that Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA) played in promoting pediatric focused drug research are highlighted. The chapter seeks to encourage cooperation between pediatricians, pharmaceutical developers, and regulatory bodies, in support of the notion that therapeutic antiviral should be truly pediatric centric. Optimizing treatment outcomes is essential to the global health of young patients and these efforts are required.
The process of modern drug discovery heavily depends on chemical biology as a technique to connect chemical science with biological research through its provision of investigative instruments for targeting and verifying drug candidate molecules. The forms of chemical probes combined with tool compounds enable new approaches in drug research because they enable precise molecular-level studies of biological processes, thus promoting better drug development. The fundamental components of drug discovery advancement rely on both chemical probes used to specify protein modifications and experimental tool compounds that help understand biological systems. Extensive disease mechanisms such as those in oncology, neurodegenerative diseases, and infectious diseases become transparent through these investigation methods, which traditional approaches fail to reveal. Extensive expansion of chemical probe libraries targeting multiple disease types will enable better comprehension of complex biological structures. The advances demonstrate significant potential for precision medicine by delivering better and segmental therapeutic approaches to treat complex diseases. The field of drug discovery experiences transformative improvements through chemical biology methods that introduce novel strategies for medical management difficulties. <!----> <!----> <!----> <!---->